Historical Stock Price
ETFs Holding ABBV »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
05/22/2017 $65.55 $65.62 $64.80 $65.44 5.54M
05/23/2017 $65.44 $66.26 $65.43 $65.84 4.68M
05/24/2017 $65.79 $66.12 $65.57 $65.93 3.17M
05/25/2017 $66.06 $66.57 $65.80 $66.32 4.06M
05/26/2017 $66.14 $66.41 $65.85 $66.06 4.06M
AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty.
ABBV historical stock prices picture
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on May 22, 2017, ABBV opened at $65.55, traded as high as $65.62 and as low as $64.80, and closed at $65.44. Trading volume was a total of 5.54M shares. On May 23, 2017, ABBV opened at $65.44, traded as high as $66.26 and as low as $65.43, and closed at $65.84. Trading volume was a total of 4.68M shares. On May 24, 2017, ABBV opened at $65.79, traded as high as $66.12 and as low as $65.57, and closed at $65.93. Trading volume was a total of 3.17M shares. On May 25, 2017, ABBV opened at $66.06, traded as high as $66.57 and as low as $65.80, and closed at $66.32. Trading volume was a total of 4.06M shares. On May 26, 2017, ABBV opened at $66.14, traded as high as $66.41 and as low as $65.85, and closed at $66.06. Trading volume was a total of 4.06M shares.

ABBV Historical Stock Prices By Date:

ABBV historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/02/2013
End date: 05/26/2017
Start price/share: $35.12
End price/share: $66.06
Starting shares: 284.74
Ending shares: 335.07
Dividends reinvested/share: $8.84
Total return: 121.35%
Average Annual Total Return: 19.82%
Starting investment: $10,000.00
Ending investment: $22,135.98
Years: 4.39
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/02/2013
End date: 05/26/2017
Start price/share: $35.12
End price/share: $66.06
Dividends collected/share: $8.84
Total return: 113.27%
Average Annual Total Return: 18.81%
Starting investment: $10,000.00
Ending investment: $21,327.65
Years: 4.39
Date Close
05/22/2017$65.44
05/23/2017$65.84
05/24/2017$65.93
05/25/2017$66.32
05/26/2017$66.06
ABBV is categorized under the Healthcare sector; below are some other companies in the same sector:

ABC Historical Stock Prices
ABEO Historical Stock Prices
ABIO Historical Stock Prices
ABMD Historical Stock Prices
ABT Historical Stock Prices
ABUS Historical Stock Prices
ACAD Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices

ABBV Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.